199 related articles for article (PubMed ID: 29953413)
1. CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson's disease by targeting miR-7.
Sang Q; Liu X; Wang L; Qi L; Sun W; Wang W; Sun Y; Zhang H
Aging (Albany NY); 2018 Jun; 10(6):1281-1293. PubMed ID: 29953413
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole Inhibits MPP
Deng C; Zhu J; Yuan J; Xiang Y; Dai L
Neurochem Res; 2020 Feb; 45(2):268-277. PubMed ID: 31811458
[TBL] [Abstract][Full Text] [Related]
3. Pramipexole attenuates neuronal injury in Parkinson's disease by targeting miR-96 to activate BNIP3-mediated mitophagy.
Wang DX; Yang Y; Huang XS; Tang JY; Zhang X; Huang HX; Zhou B; Liu B; Xiao HQ; Li XH; Yang P; Zou SC; Liu K; Wang XY; Li XS
Neurochem Int; 2021 Jun; 146():104972. PubMed ID: 33493581
[TBL] [Abstract][Full Text] [Related]
4. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.
Zhang J; Yang Y; Zhou C; Zhu R; Xiao X; Zhou B; Wan D
Bioengineered; 2022 Feb; 13(2):4493-4516. PubMed ID: 35137671
[TBL] [Abstract][Full Text] [Related]
5. Administration of resveratrol improved Parkinson's disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1/miR-129/SNCA signaling pathway.
Xia D; Sui R; Zhang Z
J Cell Biochem; 2019 Apr; 120(4):4942-4951. PubMed ID: 30260025
[TBL] [Abstract][Full Text] [Related]
6. Pramipexole attenuates 6-OHDA-induced Parkinson's disease by mediating the Nurr1/NF-κB pathway.
Gao H; Wang D; Wang YL; Mao JP; Jiang S; Yang XL
Mol Biol Rep; 2021 Apr; 48(4):3079-3087. PubMed ID: 33891271
[TBL] [Abstract][Full Text] [Related]
7. MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
Li W; Jiang Y; Wang Y; Yang S; Bi X; Pan X; Ma A; Li W
Neurosci Lett; 2018 May; 675():83-88. PubMed ID: 29608948
[TBL] [Abstract][Full Text] [Related]
8. miR-30b protects nigrostriatal dopaminergic neurons from MPP(+)-induced neurotoxicity via SNCA.
Shen YF; Zhu ZY; Qian SX; Xu CY; Wang YP
Brain Behav; 2020 Apr; 10(4):e01567. PubMed ID: 32154657
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MicroRNA-133a Inhibits Apoptosis and Autophagy in a Cell Model of Parkinson's Disease by Downregulating Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1).
Lu W; Lin J; Zheng D; Hong C; Ke L; Wu X; Chen P
Med Sci Monit; 2020 Jul; 26():e922032. PubMed ID: 32713934
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.
Tatura R; Kraus T; Giese A; Arzberger T; Buchholz M; Höglinger G; Müller U
Parkinsonism Relat Disord; 2016 Dec; 33():115-121. PubMed ID: 27717584
[TBL] [Abstract][Full Text] [Related]
11. Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson's disease.
Tarale P; Daiwile AP; Sivanesan S; Stöger R; Bafana A; Naoghare PK; Parmar D; Chakrabarti T; Krishnamurthi K
Toxicol In Vitro; 2018 Feb; 46():94-101. PubMed ID: 28986288
[TBL] [Abstract][Full Text] [Related]
12. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease.
Wang Y; Yu X; Zhang P; Ma Y; Wang L; Xu H; Sui D
J Pharmacol Sci; 2018 Sep; 138(1):31-37. PubMed ID: 30241783
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
15. Protective role of microRNA-221 in Parkinson's disease.
Li L; Xu J; Wu M; Hu JM
Bratisl Lek Listy; 2018; 119(1):22-27. PubMed ID: 29405726
[TBL] [Abstract][Full Text] [Related]
16. Astaxanthin suppresses endoplasmic reticulum stress and protects against neuron damage in Parkinson's disease by regulating miR-7/SNCA axis.
Shen DF; Qi HP; Ma C; Chang MX; Zhang WN; Song RR
Neurosci Res; 2021 Apr; 165():51-60. PubMed ID: 32333925
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson's Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways.
Liu Y; Song Y; Zhu X
Med Sci Monit; 2017 Apr; 23():1597-1606. PubMed ID: 28365714
[TBL] [Abstract][Full Text] [Related]
19. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Su C; Yang X; Lou J
Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
[TBL] [Abstract][Full Text] [Related]
20. LincRNA-p21 Inhibits Cell Viability and Promotes Cell Apoptosis in Parkinson's Disease through Activating α-Synuclein Expression.
Xu X; Zhuang C; Wu Z; Qiu H; Feng H; Wu J
Biomed Res Int; 2018; 2018():8181374. PubMed ID: 30671473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
